Literature DB >> 21156413

The G1359A-CNR1 gene polymorphism is associated to glioma in Spanish patients.

Mercedes Núñez1, Sandra Perdomo, Juan Moreta, Ángel Santos-Briz, Rogelio González-Sarmiento.   

Abstract

INTRODUCTION: The cannabinoid receptor gene 1 (CNR1) encodes the human cannabinoid receptor CB1. This receptor has a widespread distribution in the central nervous system (CNS), the main ligands being anandamide, 2-araquidonoil glycerol and marijuana constituents. There is evidence to suggest an anti-neoplastic effect of these ligands in glial tissues mediated through stimulation of the receptor.
MATERIAL AND METHODS: We have studied the G1359A polymorphism of the gene CNR1 with a TaqMan allelic discrimination assay in 200 patients diagnosed with glioma, 109 patients diagnosed with meningioma and 403 healthy subjects. Results Genotypic distribution of the G1359A CNR1 polymorphism in glioma patients showed significant differences when compared to the control group. DISCUSSION: Our results suggest that allele G of the CNR1 gene could be associated with a lower susceptibility to glioma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21156413     DOI: 10.1007/s12094-010-0604-7

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  31 in total

Review 1.  Control of the cell survival/death decision by cannabinoids.

Authors:  M Guzmán; C Sánchez; I Galve-Roperh
Journal:  J Mol Med (Berl)       Date:  2001       Impact factor: 4.599

Review 2.  Malignant glioma: genetics and biology of a grave matter.

Authors:  E A Maher; F B Furnari; R M Bachoo; D H Rowitch; D N Louis; W K Cavenee; R A DePinho
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

3.  Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation.

Authors:  I Galve-Roperh; C Sánchez; M L Cortés; T Gómez del Pulgar; M Izquierdo; M Guzmán
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

4.  Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1.

Authors:  S Leroy; N Griffon; M C Bourdel; J P Olié; M F Poirier; M O Krebs
Journal:  Am J Med Genet       Date:  2001-12-08

5.  Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

Authors:  C Sánchez; M L de Ceballos; T Gomez del Pulgar; D Rueda; C Corbacho; G Velasco; I Galve-Roperh; J W Huffman; S Ramón y Cajal; M Guzmán
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

6.  Delta9-tetrahydrocannabinol increases C6 glioma cell death produced by oxidative stress.

Authors:  I Goncharov; L Weiner; Z Vogel
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 7.  The endocannabinoid nervous system: unique opportunities for therapeutic intervention.

Authors:  A C Porter; C C Felder
Journal:  Pharmacol Ther       Date:  2001-04       Impact factor: 12.310

Review 8.  Genetic pathways to primary and secondary glioblastoma.

Authors:  Hiroko Ohgaki; Paul Kleihues
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

9.  Variations in the cannabinoid receptor 1 gene predispose to migraine.

Authors:  Gabriella Juhasz; Judit Lazary; Diana Chase; Emma Pegg; Darragh Downey; Zoltan G Toth; Kathryn Stones; Hazel Platt; Krisztina Mekli; Antony Payton; Ian M Anderson; J F William Deakin; Gyorgy Bagdy
Journal:  Neurosci Lett       Date:  2009-06-17       Impact factor: 3.046

10.  Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study.

Authors:  M Herkenham; A B Lynn; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  J Neurosci       Date:  1991-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.